ABSTRACT
INTRODUCTION Type1diabetesmellitus(T1DM)isstill consideredtobethecommonerformofdiabe-tesmellitusinyoungpeople.However,T1DM hasnotbeenreportedintheliteratureinany childoradolescentknowntohavefullAmeri-canIndianheritage.Noneoftheprobablecase subjectswithtype1diabetesdescribedina recentstudy1populationwereknowntobe offullAmericanIndianheritage2.
We have recently reported3 on latent autoimmunediabetesoftheadult(LADA)in aXavante-JêIndianfromthewesterngroups oftheSangradourocommunityinPoxoréu, StateofMatoGrosso,Brazil.Here,weshow thefirstcaseofdiabetesinaSouthAmerican IndianchildfromtheYanomamireservein thetropicalrainforestofnorthernBraziland southernVenezuela.
CASE REPORT A6-year-oldYanomamiIndiangirlwas referredtotheDiabetesCenterofUniversi-dadeFederaldeSãoPaulo(Unifesp)tocontrol herdiabetes.Thisdiseasewasdiagnosedatthe ageoftwoyears,duringtreatmentforatuber-culosisinfection.Atthattime,shedeveloped fatigue,thirst,polyuria,weightlossandfasting bloodglucose(FBG)of480mg/dl.Following this, she was given the recommendation to haveadailyshotofinsulin(0.5units/kgof bodyweight),butherfamilyrefusedtogive her the shots, and so this therapy became irregular. Over the last three years, she has presented three diabetic ketoacidosis crises. She is the ninth daughter of short-stature parents.Thereisnohistoryofdiabetesmel-litusinherfamily.
WhenshewasfirstseenattheDiabetes Center,herphysicalexaminationwasnormal, despiteherheightofonly92cm(-3.7standard deviations,SD)andweightofonly12.1kg (-2.1SD).
ShehadFBGof510mg/dl,nega-tiveketonuria,HbA1c[glycatedhaemoglobin of7.8%(normalvalue,nv:2.5-5.5%),normal albuminuriaandnormalretinalexamination. Autoantibodiesdirectedagainstglutamicacid decarboxylase (GAD-65) and tyrosine phos-phatase-relatedenzymeproteins(ICA512/IA2) weremeasuredusingquantitativeradiobinding assays.Anti-GAD65wasnegativeontwodif-ferentoccasions(GAD65Abindex:0.21and –0.02U;nv<0.22U)andtheICA512/IA2 Abindexwas3.71U/ml(nv<0.97U/ml).At thistime,thepatient’sfastingserumC-peptide (FCP)level,measuredbyradioimmunoassay, was 0.64 pmol/ml (nv: 0.11-1.2 pmol/ml). Her human leukocyte antigen (HLA) typ-ing showed DRB1*0411, DQA1*0303, DQB1*0302/DRB1*14, DQA1*0503 and DQB1*0307.Thesehaplotypeswereidentical tothoseofherparents.
Overatwo-weekperiod,whileherparents wereattendingadiabeteseducationprogram, her glycemic levels became normalized by means of human pre-mixture (80N/20R) insulin before breakfast and supper (0.9 units/kg/day).Shethenwentbackhometo theYanomamiIndianreserve.
DISCUSSION TherearetwelvethousandYanomamiIn-diansalivetoday4,inabout230villages,witha populationofaround150-200individualsin eachvillage(95%oftheminsidetheAmazon forestandtheothersalongthemajorrivers).4 They have had contact with the civilized worldonlyoverthelast20years.4Theirdiet (sweet potatoes, vegetables and bananas) is monotonous.Their most common illnesses are malaria, infectious diarrhea and acute respiratorydiseases.4
Bloch et al., studying an Indian adult population from this group, found higher meancapillarybloodglucoseamongwomen than among men, although still within the
Case R
epor
t
MônicaAndradeLimaGabbay
EdsonBussad
LigiaPersoli
WalkiriaVolpini
SérgioAtalaDib
Diabetesmellitusinayoung
AmazonIndianchild
DiabetesCenter,UniversidadeFederaldeSãoPaulo—EscolaPaulistade
Medicina,SãoPaulo,Brazil
CONTEXT:Althoughtype2diabeteshasbeen describedamongAmericanIndianchildren,no caseoftype1diabeteshasbeenreportedin theliterature.
CASEREPORT:Wereportthefirstcaseofdiabetes inaSouthAmericanIndianchildfromthetropical rainforest,whowaspositiveforIA2autoantibod-iesandgeneticmarkersofsusceptibilitytotype 1diabetes,butalsodemonstratedresidualbeta cellfunctionfouryearsafterdiagnosis.
KEYWORDS:DiabetesMellitus.EthnicGroups. HLAantigens.Southamericanindians.Autoan-tibodies.C-peptide.
94
normal range.These blood glucose levels correlated with the body mass index and waist-to-hipcircumferenceratio.5
ThediabeticYanomamichildreportedon here expressed the DRB1*04-DQB1*0302 haplotypethatisassociatedwithsusceptibility totype1diabetesinCaucasiansandalsoin our mixed Brazilian population.6 Further-more,wefoundagreatdiversityofDRB1*04 allelesinBrazilianfamilieswithtype1diabetes inourpreviousstudy.
Her FCP (0.64 pmol/ml) was higher thantheDiabetesControlandComplication Trial(DCCT)criterion(lessthan0.2pmol/ ml) to insulin-dependent diabetes mellitus (IDDM).7This FCP level suggests that she stillhadresidualbetacellfunctionfouryears after the clinical diagnosis.The absence of GAD65antibodiesinthisgirlcouldbedue toantibodiesbecomingseronegativeduring disease evolution or it could suggestType 1Bdiabetes.Itisinterestingthat,someyears ago,wereported8onacaseofyoungIndian manfromanothergroup(Krenak-Macro-Jê) whose diabetes was diagnosed by means of spontaneous ketoacidosis, but who did not haveautoantibodies(anti-insulinandisletbeta cells)andhadanormalFCP(0.95pmol/ml). Therefore,bothcasescouldbeclassifiedini-
tiallyasatypicaldiabetes.Recently,themeta-bolicandimmunologicalfeaturesofChinese patients with atypical diabetes mellitus has alsobeendescribed.9
Idiopathictype1diabetes,bydefinition, hasnoknownetiology.Individualswiththis form of diabetes can have heterogeneous clinicalmanifestations.InAfrican-American patients,ithasbeencalledatypicaldiabetes or flatbush diabetes.These individuals can have diabetic ketoacidosis as their initial clinical presentation, but autoimmune islet cellmarkersareabsentatdiagnosisandthey havephysicalcharacteristicssimilartotype2 diabetespatients.10
Asianidiopathictype1diabetescaseshave differentfeatures.Urakamietal.11reported, among85Japanesechildrenwithtype1dia-betes,that16.5%hadanewsubtypeoftype 1diabetesthatwascharacterizedbyfulminant onset,absoluteinsulindeficiencyandabsence of beta-cell autoimmunity markers.These patients had high-risk HLA typing (either HLA-DR4orDR9)andloworundetectable serumC-peptidevalues.
Harwelletal.,12 studyingayoungAmeri-canIndianpopulation(aged<20years)from MontanaandWyoming(UnitedStates),con-sideredthatchildrenwithdiabeteshadtype1 diabetesifaged≤5years,withweight-for-age lower than the 15th percentile at diagnosis
or positive results from islet cell antibody testslessthanoneyearafterdiagnosis.They consideredchildrentohaveprobabletype2 diabetesiftheirweight-for-agewas≥85th per-centile,acanthosisnigricanswasnoted,serum C-peptideorinsulinwashighwithinoneyear ofdiagnosis,therewasafamilyhistoryoftype 2diabetes,oralhypoglycemicagentswithor withoutinsulinwereusedatfollow-upmore thanoneyearafterdiagnosis,ortherewasno currentpharmacologicaltreatmentoneyear afterdiagnosis.
In accordance with these criteria our diabeticIndianchildhadthecharacteristics oftype1(agelessthan5yearsatdiagnosis, lowbodyweight,positiveforIA2antibodies, genetic markers for type 1 diabetes and in need of insulin treatment since diagnosis). Nonetheless,shestillhadresidualendogenous insulinsecretion,asshownbyFCPlevels.
Insummary,thisAmazonIndianempha-sizes the difficulty in accurately classifying diabetesbytypeamongyoungpeoplefrom thesameethnicgroups.
Population-basedstudiesthatcharacterize bothresidualbeta-cellfunctionandmultiple autoimmune antibodies serially are needed todefinethenaturalhistoryofdiabetesand clarifythepotentialheterogeneityofthedis-easeinyoungIndianpopulations.
1.HarwellTS,McDowallJM,MooreK,Fagot-CampagnaA,Hel-gersonSD,GohdesD.Establishingsurveillancefordiabetesin AmericanIndianyouth.DiabetesCare.2001;24(6):1029-32. 2.Maturity-onsetdiabetesinyoungblackAmericans.NEnglJMed.
1987;317(6):380-2.
3.VieiraFilhoJP,MoisésRC,deSáJR,ChacraAR,DibSA.Latent autoimmunediabetesoftheadult(LADA)inaBrazilianIndian. SaoPauloMedJ.2001;119(2):84-5.
4.Albert B. Yanomami. Available from URL: http://www.socio-ambiental.org/pib/epi/yanomami/print.htm. Accessed in 2005(Mar02).
5.BlochKV,CoutinhoESF,LôboMSC,OliveiraJEP,MilechA. Pressãoarterial,glicemiacapilaremedidasantropométricasem umapopulaçãoyanomámi.[Bloodpressure,capillaryglucose, andanthropometricmeasurementsinayanomámipopulation. CadSaúdePública.1993;9(4):428-38.
6.VolpiniWM,TestaGV,MarquesSB,etal.Family-basedassocia-tionofHLAclassIIallelesandhaplotypeswithtypeIdiabetes inBraziliansrevealssomecharacteristicsofahighlydiversified population.HumanImmunol.2001;62(11):1226-33. 7.TheDiabetesControlandComplicationsTrial(DCCT).Design
andmethodologicconsiderationsforthefeasibilityphase.The DCCTResearchGroup.Diabetes.1986;35(5):530-45.
8.VieiraFilhoJPB,AguadéLCM,AugustoSS,SáJR,DibSA.Ce-toacidosediabéticaemíndioKrenak.[Ketoacidosisdiabeticin Krenakindian].RevAssocMedBras.1992;38(1):28-30.
9.TanKC,MackayIR,ZimmetPZ,HawkinsBR,LamKS.Meta-bolicandimmunologicfeaturesofChinesepatientswithatypical diabetesmellitus.DiabetesCare.2000;23(3):335–8. 10.Piñero-PiloñaA,LitonjuaP,Aviles-SantaL,ReskinP.Idiopathic
type1diabetesinDallas,Texas:a5-yearexperience.Diabetes Care.2001;24(6):1014-8.
110.UrakamiT,NakagawaM,MorimotoS,KubotaS,OwadaM, HaradaK.Asubtypeofmarkedlyabruptonsetwithabsolute insulin deficiency in idiopathic type 1 diabetes in Japanese children.DiabetesCare.2002;25(12):2353–4.
12.HarwellTS,McDowallJM,MooreK,Fagot-CampagnaA,Hel-gersonSD,GohdesD.Establishingsurveillancefordiabetesin AmericanIndianyouth.DiabetesCare.2001;24(6):1029-32.
SourcesofFunding:Notdeclared
Conflictsofinterest:None
Dateoffirstsubmission:June3,2004
Lastreceived:March3,2005
Accepted:March4,2005
REFERENCES
95
AUTHOR INFORMATION
MônicaAndradeLimaGabbay,MD,MSc.Diabetes Center, Universidade Federal de São Paulo — Escola PaulistadeMedicina,SãoPaulo,Brazil.
Edson Bussad, MD.UniversidadeFederaldeRoraima, Roraima,Brazil.
Ligia Persoli, MD, PhD. Histocompatibility Laboratory, HemotherapyCenter,UniversidadedeCampinas,Campi-nas,SãoPaulo,Brazil.
Walkiria Volpini MD, PhD. HistocompatibilityLabora-tory, Hemotherapy Center, Universidade de Campinas, Campinas,SãoPaulo,Brazil
SergioAtalaDib,MD,PhD.DiabetesCenter,Universi-dadeFederaldeSãoPaulo—EscolaPaulistadeMedicina, SãoPaulo,Brazil.
Addressforcorrespondence: SergioAtalaDib
DisciplinadeEndocrinologia,UniversidadeFederal deSãoPaulo
RuaBotucatu,740—2oandar
SãoPaulo(SP)—Brasil—CEP04034-970 Tel.(+5511)5576-4235—(+5511)5571-9826 Email:sadib@endocrino.epm.br
Copyright©2005,AssociaçãoPaulistadeMedicina
RESUMO DiabetesMellitusemumacriançaindígenadoAmazonas
CONTEXTO:Odiabetesmellitustipo2temsidodescritoempopulaçõesindígenas,mascasosdediabetes
mellitustipo1sãorarosemuitasvezesnãobemcaracterizados,devidoàscondiçõesinerentesaomeio emquehabitamosíndios.
RELATODECASO: Nósrelatamosaquioprimeirocasodediabetesdotipo1emumacriançaindíge-nadaAméricadoSul,provenientedaflorestaAmazônica,caracterizadopormarcadoresgenéticos, imunológicos e clínicos, mas que apresentava função residual das células beta após quatro anos do diagnóstico,oquepodedificultar,àsvezes,acaracterizaçãoclínicadotipoespecificodediabetesem algumaspopulações.
PALAVRAS-CHAVE:DiabetesMellitus.Índio.AntígenosHLA.Auto-anticorpos.PeptídeoC.Gruposétnicos. Índiossul-americanos.